Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hajek (2020)
Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial.
Population Clinical
Cessation
Tobacco
hajek (2022)
The “gateway” effect of e-cigarettes may be explained by a genetic liability to risk-taking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hall (2021)
E-Cigarette Flavors, Devices, and Brand Preferences among Youths in Canada, England, and the United States: The Value and Challenges of Comparing International Survey Data.
Population Clinical
Consumer Use
Youth Use & Appeal
hallingberg (2022)
have e-cigarettes renormalised or displaced youth smoking? Results of a segmented regression analysis of repeated cross sectional survey data in England, Scotland and Wales.
Population Clinical
Consumer Use
Youth Use & Appeal
hallingberg (2020)
Perceived risks and benefits of smoking: differences among adolescents with different smoking experiences and intentions
Population Clinical
Perception Of Risk
Comparsion With Tobacco And Other Nicotine Products
halpern-Felsher (2004)
analysis of Toxic Metals in Electronic Cigarette aerosols Using a Novel Trap Design.
Nonclinical
Chemical
Analysis
halstead (2020)
Pilot Study to Detect Genes Involved in DNa Damage and Cancer in humans: Potential Biomarkers of Exposure to E-Cigarette aerosols.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
hamad (2021)
Exposure of U.S. workers to environmental tobacco smoke.
Nonclinical
Respiratory Toxicity
In Vivo
hammond (1999)
Occupational Exposure to Environmental Tobacco Smoke
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
hammond (1995)